SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-379354
Filing Date
2012-09-04
Accepted
2012-09-04 17:21:58
Documents
6
Period of Report
2012-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d406322d8k.htm 8-K 19686
2 OPINION OF WHITE SUMMERS CAFFEE & JAMES, LLP. d406322dex51.htm EX-5.1 8200
3 AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT d406322dex101.htm EX-10.1 185307
4 PRESS RELEASE d406322dex991.htm EX-99.1 7023
5 GRAPHIC g406322g20p53.jpg GRAPHIC 16052
6 GRAPHIC g406322g35h62.jpg GRAPHIC 12894
  Complete submission text file 0001193125-12-379354.txt   261857
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 121071761
SIC: 2834 Pharmaceutical Preparations